CompletedNot Applicable

Non-interventional-study With Tacrolimus Sandoz© Capsules for Prophylaxis of Renal Graft Rejection

Austria102 participantsStarted 2011-04

Plain-language summary

This non-interventional study intends to collect epidemiological data in patients with stable kidney function after renal transplantation, who receive Tacrolimus Sandoz© according to the approved indication.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age: ≥ 18 * Post renal transplantation time: ≥ 6 months * Stable kidney function ( serum creatinine \< 3.0mg/dl; variation \< 0.5mg/dl at 2 appointments in minimum distance of 6 days) * Stable Tacrolimus Sandoz© dose \> 2 weeks before inclusion in this Non Interventional Study (NIS) * Written and oral informed consent Exclusion Criteria: * Well-known poor compliance with immunosuppressives * Acute rejection reaction within the past 3 months or antibody-therapy because of rejection within the past 6 months

What they're measuring

Changes in Adport Sandoz© trough level

Timeframe: Observation time: 26 weeks

Trial details

NCT IDNCT01353417

SponsorSandoz

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2015-08-31

View on ClinicalTrials.gov More Chronic Kidney Insufficiency trials